Loading...
Biomarkers for Allogeneic HCT Outcomes
Allogeneic hematopoietic cell transplantation (HCT) remains the only curative therapy for many hematological malignant and non-malignant disorders. However, key obstacles to the success of HCT include graft-versus-host disease (GVHD) and disease relapse due to absence of graft-versus-tumor (GVT) eff...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7186420/ https://ncbi.nlm.nih.gov/pubmed/32373125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00673 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|